NS: 25332330
Mobile: 90094424
2:00 – 6:00 pm (weekdays)
Sat. 10:30 AM - 1:30 PM.

News & Articles

14/05/2020

Repurposed drug helps obese mice lose weight, improve metabolic function

Treatment with disulfiram, normally prescribed to treat alcohol use disorder, shows health benefits in animal study. Read More

11/05/2020

Coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key, NIH experts say

More than one effective vaccine approach likely will be required to successfully protect the global community from SARS-CoV-2. Read More

08/05/2020

NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins

The trial is now enrolling hospitalized adults with COVID-19 in the United States. Read More

07/05/2020

NIH-supported research survey to examine impact of COVID-19 on rare diseases community

For the millions of people living with a rare disease, the novel coronavirus disease COVID-19 presents unique challenges. Read More

07/05/2020

Emergency drug overdose visits associated with increased risk for later suicide

NIH-funded study highlights importance of emergency department-based interventions for mitigating suicide risk. Read More

07/05/2020

NIH-funded study links early sleep problems to autism diagnosis among at-risk children

Previous research has shown that young children who have a sibling with ASD are at a higher risk for also being diagnosed with the condition. Read More

05/05/2020

MRI technique could reduce need for radiation in measuring tumor response to chemotherapy

NIH-funded study may have implications for pediatric cancer treatment. Read More

05/05/2020

NIH Statement on World Asthma Day 2020

Asthma is a chronic lung disease that causes periods of wheezing, chest tightness, shortness of breath, and coughing. Read More

04/05/2020

Study to determine incidence of novel coronavirus infection in U.S. children begins

NIH-funded study also will ascertain percentage of infected children who develop COVID-19. Read More

29/04/2020

NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19

Preliminary results indicate that patients who received remdesivir had a 31% faster time to recovery than those who received placebo. Read More

slot depo 10k
slot server hongkong
spaceman slot
gatotkaca slot
slot bonus new member 100
mahjong ways
scatter hitam mahjong